In silico prediction of drug-induced liver injury with a complementary integration strategy based on hybrid representation
被引:1
|
作者:
Gu, Yaxin
论文数: 0引用数: 0
h-index: 0
机构:
East China Univ Sci & Technol, Sch Pharm, Shanghai Key Lab New Drug Design, Shanghai Frontiers Sci Ctr Optogenet Techn Cell Me, Shanghai, Peoples R ChinaEast China Univ Sci & Technol, Sch Pharm, Shanghai Key Lab New Drug Design, Shanghai Frontiers Sci Ctr Optogenet Techn Cell Me, Shanghai, Peoples R China
Gu, Yaxin
[1
]
Wang, Yimeng
论文数: 0引用数: 0
h-index: 0
机构:
East China Univ Sci & Technol, Sch Pharm, Shanghai Key Lab New Drug Design, Shanghai Frontiers Sci Ctr Optogenet Techn Cell Me, Shanghai, Peoples R ChinaEast China Univ Sci & Technol, Sch Pharm, Shanghai Key Lab New Drug Design, Shanghai Frontiers Sci Ctr Optogenet Techn Cell Me, Shanghai, Peoples R China
Wang, Yimeng
[1
]
Wu, Zengrui
论文数: 0引用数: 0
h-index: 0
机构:
East China Univ Sci & Technol, Sch Pharm, Shanghai Key Lab New Drug Design, Shanghai Frontiers Sci Ctr Optogenet Techn Cell Me, Shanghai, Peoples R ChinaEast China Univ Sci & Technol, Sch Pharm, Shanghai Key Lab New Drug Design, Shanghai Frontiers Sci Ctr Optogenet Techn Cell Me, Shanghai, Peoples R China
Wu, Zengrui
[1
]
Li, Weihua
论文数: 0引用数: 0
h-index: 0
机构:
East China Univ Sci & Technol, Sch Pharm, Shanghai Key Lab New Drug Design, Shanghai Frontiers Sci Ctr Optogenet Techn Cell Me, Shanghai, Peoples R ChinaEast China Univ Sci & Technol, Sch Pharm, Shanghai Key Lab New Drug Design, Shanghai Frontiers Sci Ctr Optogenet Techn Cell Me, Shanghai, Peoples R China
Li, Weihua
[1
]
Liu, Guixia
论文数: 0引用数: 0
h-index: 0
机构:
East China Univ Sci & Technol, Sch Pharm, Shanghai Key Lab New Drug Design, Shanghai Frontiers Sci Ctr Optogenet Techn Cell Me, Shanghai, Peoples R ChinaEast China Univ Sci & Technol, Sch Pharm, Shanghai Key Lab New Drug Design, Shanghai Frontiers Sci Ctr Optogenet Techn Cell Me, Shanghai, Peoples R China
Liu, Guixia
[1
]
Tang, Yun
论文数: 0引用数: 0
h-index: 0
机构:
East China Univ Sci & Technol, Sch Pharm, Shanghai Key Lab New Drug Design, Shanghai Frontiers Sci Ctr Optogenet Techn Cell Me, Shanghai, Peoples R China
East China Univ Sci & Technol, Sch Pharm, Shanghai Key Lab New Drug Design, Shanghai Frontiers Sci Ctr Optogenet Techn Cell Me, Shanghai 200237, Peoples R ChinaEast China Univ Sci & Technol, Sch Pharm, Shanghai Key Lab New Drug Design, Shanghai Frontiers Sci Ctr Optogenet Techn Cell Me, Shanghai, Peoples R China
Tang, Yun
[1
,2
]
机构:
[1] East China Univ Sci & Technol, Sch Pharm, Shanghai Key Lab New Drug Design, Shanghai Frontiers Sci Ctr Optogenet Techn Cell Me, Shanghai, Peoples R China
[2] East China Univ Sci & Technol, Sch Pharm, Shanghai Key Lab New Drug Design, Shanghai Frontiers Sci Ctr Optogenet Techn Cell Me, Shanghai 200237, Peoples R China
Drug-induced liver injury (DILI) is one of the major causes of drug withdrawals, acute liver injury and blackbox warnings. Clinical diagnosis of DILI is a huge challenge due to the complex pathogenesis and lack of specific biomarkers. In recent years, machine learning methods have been used for DILI risk assessment, but the model generalization does not perform satisfactorily. In this study, we constructed a large DILI data set and proposed an integration strategy based on hybrid representations for DILI prediction (HR-DILI). Benefited from feature integration, the hybrid graph neural network models outperformed single representation-based models, among which hybrid-GraphSAGE showed balanced performance in cross-validation with AUC (area under the curve) as 0.804 +/- 0.019. In the external validation set, HR-DILI improved the AUC by 6.4 %-35.9 % compared to the base model with a single representation. Compared with published DILI prediction models, HR-DILI had better and balanced performance. The performance of local models for natural products and synthetic compounds were also explored. Furthermore, eight key descriptors and six structural alerts associated with DILI were analyzed to increase the interpretability of the models. The improved performance of HR-DILI indicated that it would provide reliable guidance for DILI risk assessment.
机构:
Univ So Calif, Keck Sch Med, Gastroenterol Liver Div, Los Angeles, CA 90033 USAUniv So Calif, Keck Sch Med, Gastroenterol Liver Div, Los Angeles, CA 90033 USA
机构:
Univ Toronto, Dept Med, Toronto, ON, Canada
Univ Toronto, Div Pharmacol Clin & Toxicol, Toronto, ON, CanadaUniv Toronto, Dept Med, Toronto, ON, Canada
Kumachev, Alexander
Wu, Peter E.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Toronto, Dept Med, Toronto, ON, Canada
Univ Toronto, Div Pharmacol Clin & Toxicol, Toronto, ON, Canada
Univ Toronto, Div Med Interne Gen, Toronto, ON, CanadaUniv Toronto, Dept Med, Toronto, ON, Canada
机构:
Ernakulam Med Ctr, Cochin Gastroenterol Grp, Liver Unit, Kochi, Kerala, India
Ernakulam Med Ctr, Cochin Gastroenterol Grp, Monarch Liver Lab, Kochi, Kerala, IndiaErnakulam Med Ctr, Cochin Gastroenterol Grp, Liver Unit, Kochi, Kerala, India
Philips, Cyriac Abby
Augustine, Philip
论文数: 0引用数: 0
h-index: 0
机构:
Ernakulam Med Ctr, Cochin Gastroenterol Grp, Gastroenterol, Kochi, Kerala, IndiaErnakulam Med Ctr, Cochin Gastroenterol Grp, Liver Unit, Kochi, Kerala, India
Augustine, Philip
Rajesh, Sasidharan
论文数: 0引用数: 0
h-index: 0
机构:
Ernakulam Med Ctr, Cochin Gastroenterol Grp, Intervent Radiol, Kochi, Kerala, IndiaErnakulam Med Ctr, Cochin Gastroenterol Grp, Liver Unit, Kochi, Kerala, India
Rajesh, Sasidharan
Kumar, Praveen Y.
论文数: 0引用数: 0
h-index: 0
机构:
Govt Med Coll, Gastroenterol, Trichur, Kerala, IndiaErnakulam Med Ctr, Cochin Gastroenterol Grp, Liver Unit, Kochi, Kerala, India
Kumar, Praveen Y.
Madhu, Deepak
论文数: 0引用数: 0
h-index: 0
机构:
Aster MIMS, Gastroenterol, Calicut, Kerala, IndiaErnakulam Med Ctr, Cochin Gastroenterol Grp, Liver Unit, Kochi, Kerala, India